Gypenoside LVI

SKU: orb3179968

Description

Gypenoside LVI inhibits LDLR degradation in lysosomes, thereby increasing LDL uptake into HepG2 cells. Gypenoside LVI also decreases PCSK9 expression induced by stains. Gypenoside LVI is utilized in lipid metabolism research focused on LDL receptor regulation, PCSK9-associated pathways, and hepatic cholesterol uptake mechanisms in hepatocyte-based model systems.

Research Area

Metabolism Research

Key Properties

• CAS Number: 105214-48-0
• MW: 1095.27
• Purity: 99.34% (May vary between batches)
• Formula: C₅₃H₉₀O₂₃
• SMILES: C[C@]12[C@@]([C@]3(C)[C@@](CC1)(C(C)(C)[C@@H](O[C@H]4[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@@H](CO)O4)[C@H](O)C3)[H])(C[C@@H](O)[C@]6([C@@]2(C)CC[C@@]6([C@@](O[C@@H]7O[C@H](CO[C@H]8[C@H](O)[C@@H](O)[C@H](O)CO8)[C@@H](O)[C@H](O)[C@H]7O)(CCC=C(C)C)C)[H])[H])[H]
• Target: LDLR

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

LDLR